128 results
Page 4 of 7
6-K
EX-99.1
cv6ldin8
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
cvkm792ggv1c52
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
npo8bnhyu 78a
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
z1k82izoeb48qqrh
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.4
pl7qek8
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
ge5wydj2slo1p9
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
vc4u 0h8fb0rcm4
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
EX-99.1
xktu3eq7b9vyceo8sd
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am
6-K
EX-99.1
g4l63ig3m4no
4 Mar 21
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
6:05am
6-K
EX-99.1
bgzzh
10 Feb 21
Current report (foreign)
11:31am
6-K
EX-99.1
dx0e5 9ll
21 Jan 21
Current report (foreign)
7:49am
6-K
EX-99.1
6mm6auni66gn
6 Jan 21
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
9:57am
6-K
EX-99.1
yr8gae1efm6z74y
5 Jan 21
Selvita completes acquisition of Fidelta from Galapagos
7:00am
6-K
EX-99.1
aq0wzzyoh00c4q0d is
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.1
pu3v6c30
3 Dec 20
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
4:34pm
6-K
EX-99.1
r1fy7
30 Nov 20
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
5:10pm
6-K
EX-99.1
mabpfq6rfqo8wn679he
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
EX-99.1
792db9
10 Nov 20
Current report (foreign)
6:05am